image
Syros Pharmaceuticals, Inc. SYRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.2593
-5.74 %
$ 6.96 M
Market Cap
-0.08
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -33.23% -233.81% 5.07%
Annual Report FY 10-K 2022-12-31 -36.65% 45.50% -36.67%
Annual Report FY 10-K 2021-12-31 55.62% -5.40% -20.81%
Annual Report FY 10-K 2020-12-31 661.50% -13.78% -5.86%
Annual Report FY 10-K 2019-12-31 -3.32% -21.13% -20.91%
Annual Report FY 10-K 2018-12-31 86.19% -15.31% -17.57%
Annual Report FY 10-K 2017-12-31 247.32% -13.13% -14.02%
Annual Report FY 10-K 2016-12-31 0.00% -60.11% -60.84%
Annual Report FY 10-K 2015-12-31 0.00% -122.01% -121.96%
Annual Report FY 10-K 2014-12-31 0.00% -45.06% -55.62%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 84.07% 24.41%
Quarterly Report Q2 8-K 2024-06-30 0.00% 35.66% 19.36%
Quarterly Report Q1 8-K 2024-03-31 0.00% 75.15% 6.90%
Quarterly Report Q4 8-K 2023-12-31 107.06% -233.49% 24.98%
Quarterly Report Q3 8-K 2023-09-30 -3.32% -90.68% 12.21%
Quarterly Report Q2 8-K 2023-06-30 -54.86% -3.03% -0.68%
Quarterly Report Q1 8-K 2023-03-31 -45.97% 36.87% -24.61%
Quarterly Report Q4 8-K 2022-12-31 -70.07% 215.80% -41.59%
Quarterly Report Q3 8-K 2022-09-30 -31.70% 19.11% -46.61%
Quarterly Report Q2 8-K 2022-06-30 21.58% -56.48% -29.17%
Quarterly Report Q1 8-K 2022-03-31 13.26% -66.14% -27.28%
Quarterly Report Q4 8-K 2021-12-31 36.90% 20.97% 12.99%
Quarterly Report Q3 8-K 2021-09-30 48.82% -33.57% -41.66%
Quarterly Report Q2 8-K 2021-06-30 61.92% -30.79% -56.17%
Quarterly Report Q1 8-K 2021-03-31 102.90% 17.40% -20.77%
Quarterly Report Q4 8-K 2020-12-31 1021.85% -52.72% -44.86%
Quarterly Report Q3 8-K 2020-09-30 586.02% 1.55% 6.83%
Quarterly Report Q2 8-K 2020-06-30 590.04% 11.61% 17.16%
Quarterly Report Q1 8-K 2020-03-31 424.01% -4.65% -2.16%
Quarterly Report Q4 8-K 2019-12-31 -43.11% -9.41% -8.40%
Quarterly Report Q3 8-K 2019-09-30 35.44% -25.77% -24.93%
Quarterly Report Q2 8-K 2019-06-30 23.20% -38.50% -38.91%
Quarterly Report Q1 8-K 2019-03-31 22.70% -13.81% -14.52%
Quarterly Report Q4 8-K 2018-12-31 0.00% -17.84% -19.89%
Quarterly Report Q3 8-K 2018-09-30 0.00% -13.83% -16.24%
Quarterly Report Q2 8-K 2018-06-30 0.00% -5.08% -7.66%
Quarterly Report Q1 8-K 2018-03-31 -66.39% -25.60% -27.62%
Quarterly Report Q4 8-K 2017-12-31 0.00% -39.55% -40.52%
Quarterly Report Q3 8-K 2017-09-30 0.00% 2.43% 1.24%
Quarterly Report Q2 8-K 2017-06-30 0.00% -11.21% -12.00%
Quarterly Report Q1 8-K 2017-03-31 0.00% -8.76% -9.19%
Quarterly Report Q4 8-K 2016-12-31 0.00% -2.58% -3.33%
Quarterly Report Q3 8-K 2016-09-30 0.00% -67.40% -67.97%
Quarterly Report Q2 8-K 2016-06-30 0.00% -97.16% -97.95%
Quarterly Report Q1 8-K 2016-03-31 0.00% -131.79% -132.63%
Quarterly Report Q4 8-K 2015-12-31 0.00% -121.49% -189.60%
Quarterly Report Q3 8-K 2015-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%